Since November, 2023, empagliflozin is now indicated in people aged 10 years as a monotherapy if metformin is not tolerated (and diet and exercise alone do not provide adequate glycaemic control), or in combination with other glucose-lowering medicines (under specialist supervision) if glycaemic control remains poor
UnitedHealth Group Probe : The U.S
[6, 7, 8] But the effect only lasts for a couple of minutes, as opposed to GLP-1 medicationswhich last for a week
Remember that very tight glucose control in early pregnancy is critical for reducing birth defect risk
When you work with Dr
Medication review : Assess for concurrent medications that may increase stone risk (loop diuretics, topiramate, acetazolamide, triamterene, indinavir, high-dose vitamin C, and vitamin D supplements, particularly when combined with calcium supplementation)